What You Should Know:
-Tempus, an $8B precision medicine company, is providing genomic sequencing for 300 eligible pediatric cancer patients annually through their new collaboration with the Children’s Oncology Group (COG). Tempus’ support for COG – a leader in pediatric oncology research – will assist with matching patients to clinical trials like the Pediatric MATCH Screening Trial APEC1621SC (NCT03155620), which is studying the effectiveness of genetic testing-directed treatment in
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
Bastion Health Launches Digital Men’s Health Clinic, Releases the First-of-Its-Kind At-Home Prostate and Male Fertility Testing Kits
What You Should Know:
- Bastion Health, the first-ever comprehensive digital men’s health clinic specializing in reproductive and prostate health, announces the first and most extensive end-to-end at-home test kits for prostate health and reproductive health, including assessment and treatment options.
- Bastion’s all-in-one ecosystem makes it the first online men’s health clinic to offer comprehensive testing, assessment and treatment options for fertility and prostate health from
Read More
Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data
What You Should Know:
- Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers.
- The study will encompass both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition,
Read More
The Fast Pace of Cancer Research is Leaving Community Clinicians Behind
We are witnessing an accelerated pace of amazing breakthroughs and advancements in cancer care today, with new treatments emerging almost weekly and unprecedented opportunities to help improve patient outcomes every day. However, if a doctor is not working in an academic setting, reading every new paper, and recruiting patients for new studies, how can they be expected to keep up with the latest treatments and approaches to specific cancers? When
Read More
Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare
Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications.
How Can Pharmacogenomics Improve Outcomes?
By considering a person’s DNA in treatment options, providers can determine how an
Read More
Femtech – Changing Dynamics of Women’s Healthcare
Femtech a term coined by Danish entrepreneur Ida Tin in 2016 has become a revolutionary moment for women across the globe. Femtech as the term suggests focuses on using technology to solve health issues in females. Although women are the primary caregivers of families, they themselves are at the receiving end of not getting treated for the ailments they suffer. This is owing to multiple reasons that range from socio-economic conditions, lack of awareness regarding health issues and less or no
Read More
Syapse and Genesis Research Form RWE Partnership in Oncology
What You Should Know:
- Today, Syapse, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases, announced that they have entered into a strategic partnership with Genesis Research.
- This partnership will focus on conducting real-world evidence-based research that supports the development and launch of new and innovative treatments.
- As part of the
Read More
Preventative Health Programs Need to Address 3 Key Components
Combination of genetic testing, custom nutrition/exercise/mental wellbeing planning, and personal coaching thwarts chronic metabolic diseases through habit change.
The most effective approach to treating chronic disease today focuses on behavior change and prevention. Condition management is yesterday’s innovation; the real key is keeping healthy people healthy in the first place. Smart preventative treatment involves highly personalized experiences informed by behavioral genetic
Read More
Intelerad Acquires PenRad Technologies
What You Should Know:
- Today, Intelerad, a leading global provider of enterprise medical imaging solutions, announced its acquisition of PenRad, a software provider for enhancing productivity for breast imaging and lung screening.
- The acquisition expands Intelerad’s product offerings for mammography and lung analytics, ensuring radiologists, technologists and other healthcare professionals can drive greater productivity and meet higher oncology screening demand, while improving patient
Read More
Philips Appoints New CEO Amid Respiratory Device Recall
What You Should Know:
- Philips today announced that Roy Jakobs is proposed to succeed Frans van Houten as President and Chief Executive Officer, effective October 15, 2022.
- The Supervisory Board and current Philips CEO Frans van Houten have agreed that with the end of his third term in sight, the time is right for the change in leadership. After a comprehensive evaluation of external and internal candidates, the Supervisory Board has unanimously decided to propose Roy Jakobs as the
Read More
